NCT03462693

Brief Summary

A single-center, observational, prospective, two dynamic cohorts study with before-after design. Group 1: Treatment with 6 sessions using dry needling with DNHS® (Dry Needling for Hypertonicity and Spasticity) on the spastic muscles of the affected arm in patients with stroke plus standard physiotherapy treatment. Group 2: Standard physiotherapy treatment. Spasticity will be assessed by Modifying Modified Ashworth Scale (MMAS), functionality with the Fugl-Meyer scale for the upper limb, motor recovery with Brunnstrom Stages Scale (BSS) and upper limb spasticity pattern (ULP), pain by 10-points Numerical Rating Scale (NRS10) and the quality of life with the Euro QoL 5D 5L survey. In both groups the valuations will be made following the same schedule.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
123

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 12, 2018

Completed
3 days until next milestone

Study Start

First participant enrolled

March 15, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2018

Completed
Last Updated

May 14, 2019

Status Verified

October 1, 2018

Enrollment Period

7 months

First QC Date

March 6, 2018

Last Update Submit

May 10, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Upper Limb Scale

    The Fugl-Meyer Upper Limb Assessment of Motor Recovery after Stroke evaluates and measures recovery in post-stroke hemiplegic patients. It consists of 4 domains formed by ordinal items of 3 points: 1 (not performed), 2 (partial execution) and 3 (complete execution). The maximum total sum score of the scale is 226. The domains are: Motor block consisting of 33 items with a maximum total sum score of 66 and consisting of the following sections: A: Upper Extremity, B: Wrist, C: Hand and D: Coordination and speed; an increase of 10 points in this block is described as a clinically important change. Three other domains are added to the motor block: H: Sensation, with 6 items with a maximum total sum score of 12, J: Passive joint movement, with 12 items with a maximum total sum score of 24 and J: Joint pain with 12 items with a total maximum sum score of 24.

    8 weeks

Secondary Outcomes (2)

  • Modification of Modified Ashworth Scale

    8 weeks

  • Euro QoL 5D quality of life scale

    8 weeks

Other Outcomes (3)

  • Numerical Rating Scale 10-points scale

    8 weeks

  • Brunnstrom Recovery Stages

    8 weeks

  • Upper limb pattern

    8 weeks

Study Arms (2)

Group 1

Dry needling plus standard physiotherapy treatment

Other: Dry needling

Group 2

Standard physiotherapy treatment

Interventions

The DNHS® dry-puncture technology is specifically marked for stroke patients. the muscle to be treated is placed in a submaximal position; the needle is inserted into the present tense bandage and mobilized in the inside and outside for about 1 minute or until the reaction of global spasm ceases

Group 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with the diagnosis of stroke inacute subacute phase entering for the first time at the Hospital Guadarrama

You may qualify if:

  • They must voluntarily understand and sign the relevant informed consent documents and information sheet, before any evaluation / procedure related to the study is conducted.
  • Male or female, ≥ 18 years old at the time of consent.
  • Have the diagnosis of hemispheric ischemic or hemorrhagic stroke without excluding other causes (surgical, traumatic, etc ...).
  • Show spasticity in the affected upper limb, with an MMAS score of 1-3 in one of the following muscle groups: finger flexors, wrist flexors, elbow flexors, forearm pronators, adductors, or internal rotators of the shoulder.

You may not qualify if:

  • Presence of stiffness (score of 4 in MMAS) or hypotonia (MMAS of 0).
  • Severe cognitive impairment, severe language problems, severe vision or hearing impairments that prevent compression and active patient collaboration during evaluation tests.
  • Have received treatment by injection of Botulinum Toxin A in the 2 months prior to the start of the study.
  • Any medical condition that contraindicates dry needling.
  • Present some contraindication for the application of dry puncture:
  • Pregnancy, insurmountable fear of needles, allergy to metals (nickel), presence of lesions in the puncture area, scars, tattoos...

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

J.Nicolas Cuenca Zaldivar

Guadarrama, Madrid, 28440, Spain

Location

MeSH Terms

Conditions

Muscle Spasticity

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Study Officials

  • Mr Cuenca Zaldivar

    Guadarrama Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Rehabilitation Service Principal Investigator

Study Record Dates

First Submitted

March 6, 2018

First Posted

March 12, 2018

Study Start

March 15, 2018

Primary Completion

October 25, 2018

Study Completion

October 25, 2018

Last Updated

May 14, 2019

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share

Locations